UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): September 14, 2004
__________
SIGA Technologies, Inc.
-----------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 0-23047 13-3864870
-------- ------- ----------
(State or other Jurisdiction of (Commission File (I.R.S. Employer
Incorporation or Organization) Number) Identification Number)
420 Lexington Avenue, Suite 601, New York, New York 10170
---------------------------------------------------- -----
(Address of Principal Executive Offices) (Zip Code)
(212) 672-9100
--------------
(Registrant's telephone number, including area code)
N/A
---
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 7.01. Required FD Disclosure.
On September 14, 2004, SIGA Technologies, Inc., a Delaware corporation,
issued a press release pursuant to which it announced that it has been
designated as a prime contractor by the U. S. Air Force Surgeon General's office
to create systems for the rational development of vaccines and therapeutics
against potential agents of biological terrorism. This development program will
be funded by an existing $4 million congressional appropriation for fiscal year
2005. The funding is part of the Department of Defense Budget that recently
passed the House and Senate and was signed by President Bush. A copy of the
press release is attached hereto as Exhibit 99.1, which is incorporated in this
Item 7.01 by reference.
ITEM 9.01 Financial Statements and Exhibits
(c) Exhibits
Exhibit No. Description
----------- -----------
99.1 Press Release dated September 14, 2004.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SIGA TECHNOLOGIES, INC.
By: /s/ Thomas N. Konatich
-----------------------------------
Thomas N. Konatich
Chief Financial Officer
Date: September 14, 2004
3
EXHIBIT INDEX
Exhibit Number Description
-------------- -----------
99.1 Press Release dated September 14, 2004.